Close Menu

Integrated Diagnostics

Steve Spotts becomes chief commercial officer of Swift Biosciences; Integrated Diagnostics adds Jay Moyes as independent director; Qiagen supervisory board proposes Vera Kallmeyer and Elizabeth Tallett for election.

Movers & Shakers: Jan 28, 2011

Premium

Kenneth Fang, Alf Lindberg, Catherin Derasp

Pairings: Jan 26, 2011

Premium

Kenneth Fang, Robert Maki, George Demetri, Judy Garber, Mark Robson

A number of prominent proteomics-based diagnostics developers were recipients of the grant and tax credit awards, which are being provided by the IRS through the Patient Protection and Affordable Care Act's Qualifying Therapeutic Discovery Project Program.

Movers & Shakers: Oct 8, 2010

Premium

Gregory Critchfield, Ian Pike, Rainer Metternich

Pairings: Oct 6, 2010

Premium

Gregory Critchfield

Paired Ends: Oct 5, 2010

Premium

Paul Billings, Robert Wall, Cliff Reid, Michael Rubin, David Baltimore, Gregory Critchfield, David Barker, Jim Heath, Lee Hood, Patrizia Luchetta, Albert Luderer, Arnold Oronsky, Subra Suresh

The company next year plans to launch a 1,000-patient verification trial for its lung cancer protein biomarker panel, with trials for its Alzheimer's disease panel likely to follow, said an official.

The company is leveraging the research of Lee Hood and using genomics and proteomics technologies to develop tests for a broad range of diseases.

Movers & Shakers: Apr 2, 2010

Premium

Collin D'Silva, Albert Luderer, Timm Jessen, Dave Lemus, Robert Huber, Ingo Köhler, Berthold Hinzen, Andre Schmutte

Pages

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.